Bionano Laboratories has validated its OGM-Dx HemeOne diagnostic test for hematologic malignancy analysis. The test is expected to be eligible for coverage under the proposed LCD once the policy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results